Skip to main content

Advertisement

SpringerLink
Log in

Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

References

  1. Farag SS . Chronic graft-versus-host disease. Bone Marrow Transplant 2004; 33: 569–577.

    Article  CAS  Google Scholar 

  2. Stasi R, Stipa E, Forte V, Meo P, Amadori S . Variable patterns of response to rituximab treatment in adults with chronic idiopathic thrombocytopenic purpura. Blood 2002; 99: 3872–3873.

    Article  CAS  Google Scholar 

  3. Ratanatharathorn V, Carson E, Reynolds C, Ayash LJ, Levine J, Yanik G et al. Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease. Ann Intern Med 2000; 133: 275–279.

    Article  CAS  Google Scholar 

  4. Ratanatharathorn V, Ayash L, Reynolds C, Silver S, Reddy P, Becker M et al. Treatment of chronic graft-versus-host disease with anti-CD20 chimeric monoclonal antibody. Biol Blood Marrow Transplant 2003; 9: 505–511.

    Article  CAS  Google Scholar 

  5. Canninga-van Dijk MR, van der Straaten HM, Fijnheer R, Sanders CJ, van den Tweel JG, Verdonck LF . Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease. Blood 2005; 104: 2603–2606.

    Article  Google Scholar 

  6. Liem LM, Fibbe WE, van Houwelingen HC, Goulmy E . Serum transforming growth factor-beta1 levels in bone marrow transplant recipients correlate with blood cell counts and chronic graft-versus-host disease. Transplantation 1999; 15: 59–65.

    Article  Google Scholar 

  7. Rouquette-Gally AM, Boyeldieu D, Prost AC, Gluckman E . Autoimmunity after allogeneic bone marrow transplantation. A study of 53 long-term-surviving patients. Transplantation 1988; 46: 238–240.

    Article  CAS  Google Scholar 

  8. Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R . Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003; 102: 1217–1223.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan

    M Okamoto, A Okano, S Akamatsu & C Shimazaki

  2. Division of Blood Transfusion and Cell Therapy, Kyoto University Hospital, Kyoto, Japan

    E Ashihara

  3. Department of Clinical Molecular Genetics and Laboratory Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan

    T Inaba

  4. Department of Dermatology, Kyoto Prefectural University of Medicine, Kyoto, Japan

    H Takenaka, N Katoh & S Kishimoto

Authors
  1. M Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Okano
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Akamatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E Ashihara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Inaba
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H Takenaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. N Katoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. S Kishimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C Shimazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okamoto, M., Okano, A., Akamatsu, S. et al. Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease. Leukemia 20, 172–173 (2006). https://doi.org/10.1038/sj.leu.2403996

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403996

  • Springer Nature Limited

This article is cited by

Search

Navigation